Preparation and evaluation of pH-dependent gradient-release pellets for TCM

Drug Development and Industrial Pharmacy

Volumn 30, Issue 10, 2004, Pages 1079-1087

  Tang, Xing ^a   Tian, XiaoLin ^a   Ci, Lei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; EUDRAGIT; GUANXIN SUHE WAN; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; DUODENUM; GUINEA PIG; HEART; HUMAN; HUMAN EXPERIMENT; ILEUM; JEJUNUM; MALE; NONHUMAN; NORMAL HUMAN; PELLET EXTRUSION; PH; STOMACH; SUSTAINED DRUG RELEASE;

ANIMALS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHINA; CINNAMATES; COMPLEX MIXTURES; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; GUINEA PIGS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOSE; MALE; MEDICINE, CHINESE TRADITIONAL; METHYLCELLULOSE; OXAZINES; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 9644290858     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-200040286     Document Type: Article

References (19)

1. Roeder, E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 2000, 55, 711-726.
2. Huang, P.L.; Huang, P.L.; Huang, P. Chem. Ind. 1992, 20, 290.
3. Gong, X.; Sucher, N.J. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol. Sci. 1999, 20, 191-196.
4. Griffith, V. Aust. J. Holist. Nurs. 1999, 6, 35.
5. Nestler, G. Traditional Chinese medicine. Med. Clin. North Am. 2002, 86, 63-73.
6. Leng, F.N.; Zhong, Z.J.; Yao, C. Renmin Weisheng Publishing House: Beijing, China, 1988.
7. Li, S.Z.; Wang, D.Z.; Li, X.Y. Discussion on modernization of research and development of TCM. Chin. Trade Herb. Drugs 2001, 32, 383-387.
8. Xu, L.Y.; Tao, J.S.; Feng, Y. Developments in pharmacy of Chinese herbal medicine in retrospect. Chin. Trade Pat. Med. 2000, 22 (1), 6-21.
9. Zhou, H.J.; Lu, Y.R. Phytotherapy in China and its prospects. J. Chin. Pharm. Sci. 1992, 1, 3-12.
10. Yuan, R.; Lin, Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharm. Ther. 2000, 86, 191-198.
11. Ch. P (2000, Part I) 544.
12. Da Ci Dian, Z.Y. Jiangsu New Medicinal College, 1975; p. 1085.
13. William, J. Elliott Timing Treatment to the Rhythm of Disease, 2nd Ed.; Postgraduate Medicine, 2001; Vol. 110.
14. Frömming, K.-H.; Szejtli, J. Topics in Inclusion Science; Cyclodextrins in Pharmacy; 1994; p. 85.
15. Muskó, Zs.; et al. Study of in vitro and in vivo dissolution of theophylline from film-coated pellets. Eur. J. Pharm. Biopharm. 2001, 51, 143-146.
16. Loftsson, T.; Brewster, M.E. Pharmaceutical applications of cyclodestrins 1. drug solubilization and stabilization. J. Pharm. Sci. 1996, 85, 1017-1025.
17. Brewster, M.E.; Loftsson, T. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie 2002, 57 (2), 94-101.
18. Chapter 1 Drugs and the Pharmaceutical Sciences. In Novel Drug Delivery Systems, 2nd Ed.; Chien, Y. W., Ed.; Marcel Dekker, Inc.: New York City, 1991; Vol 50.
19. Santang, Z. Research Progresses in the Pharmacokinetics of TCMCR J, 3rd Ed.; ANHUI TCM COLLEGE, 2000; Vol. 19, 58-61.